Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid
- PMID: 7376944
- DOI: 10.1007/BF01400945
Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid
Abstract
Tranexamic acid as an antifibrinolytic agent has been investigated in a controlled study in patients with recent subarachnoid haemorrhage. It is concluded that tranexamic acid improves neither rebleeding rates, nor mortality. Predominantly thrombotic complications have been noted as a more serious side effect of tranexamic acid.